Conducts and supports research on the prevention and early detection of prostate and bladder cancer. Clinical trials and the evaluation of new agents, surrogate biomarkers, and new technologies to identify premalignant lesions are developed and supported.
This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group's key programs.
Research focuses on prostate and bladder cancer clinical trials.
Mission, staff list, and contact information are in this section.
Back to top
